Last $8.65 USD
Change Today +0.13 / 1.53%
Volume 173.6K
SUPN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack A. Khattar

Founder, Chief Executive Officer, President, Secretary and Director, Supernus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
53$2,588,289
As of Fiscal Year 2013

Background*

Mr. Jack A. Khattar Founded Supernus Pharmaceuticals, Inc. (Formerly, Shire Laboratories, Inc.) and has been its Chief Executive Officer and President since 2005. Mr. Khattar serves as Secretary of Supernus Pharmaceuticals, Inc. Mr. Khattar served as President and Chief Executive Officer of Shire Pharmaceuticals Group plc since May 1999. Mr. Khattar has 19 years of industry experience in the development and commercialization of pharmaceutical products and drug delivery ...

Read Full Background

Corporate Headquarters*

1550 East Gude Drive
Rockville, Maryland 20850

United States

Phone: 301-838-2500
Fax: --

Board Members Memberships*

2005-Present
Founder, Chief Executive Officer, President, Secretary and Director

Education*

BBA
American University of Beirut
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$462,938
Total Annual Compensation$462,938

Stock Options*

All Other Compensation$15,251
Unexercisable Options392,000
Total Number of Options392,000

Total Compensation*

Total Annual Cash Compensation$709,939
Total Short Term Compensation$462,938
Other Long Term Compensation$15,251
Total Calculated Compensation$2,588,289
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUPN:US $8.65 USD +0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERNUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.